Biotech Review of the Year
Now in its 13th year, our annual Biotech Review of the Year is an overview of some of the recent key developments in the sector. We take a look at market trends and the issues critical to those in the biotech industry.
Welcome to the 13th edition of our Biotech Review of the Year, bringing together practical legal, regulatory and commercial insights shaping the biotech sector.
This year’s Review explores key developments across cell and gene therapies, the evolving regulatory landscape, increased competition scrutiny, and litigation trends across the UK and Europe.
It also features industry perspectives on the changing environment for biotech companies and the role of in‑house counsel.
Download now to explore practical guidance and strategic insight for those operating across the biotech sector.
Aida Tohala and Erik Müürsepp share a snapshot of what is included in this edition.
Issue 13
Follow the links below to read every article by chapter:
